Lyell Immunopharma, Inc. ($LYEL)
Filing Information
| Accession Number | 0001907345-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
54,147
Total Value
$3,398.64
P&L
+inf% (+$1,032,480.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 9, 2026 | Grant/Award | 4,000 | $0.00 | $0.00 | 18,756 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 10, 2026 | Sale | 147 | $23.12 | $3,398.64 | 18,609 | Direct | โ | View Details | |
Chief Scientific Officer | Option (right to buy) | Derivative | Feb 10, 2026 | Grant/Award | 50,000 | $0.00 | $0.00 | 50,000 | Direct | โ | View Details |